HomeUTHR • NASDAQ
add
United Therapeutics Corporation
Previous close
$234.47
Day range
$233.28 - $241.00
Year range
$204.44 - $261.54
Market cap
11.15B USD
Avg Volume
521.52K
P/E ratio
11.96
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 614.70M | 25.07% |
Operating expense | 282.50M | 14.00% |
Net income | 217.10M | 64.35% |
Net profit margin | 35.32 | 31.40% |
Earnings per share | 4.36 | 19.68% |
EBITDA | 274.90M | 38.77% |
Effective tax rate | 26.51% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.99B | 5.47% |
Total assets | 7.17B | 18.57% |
Total liabilities | 1.18B | -5.26% |
Total equity | 5.98B | — |
Shares outstanding | 47.06M | — |
Price to book | 1.84 | — |
Return on assets | 9.20% | — |
Return on capital | 9.87% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 217.10M | 64.35% |
Cash from operations | 150.70M | 17.55% |
Cash from investing | 42.10M | 122.24% |
Cash from financing | -92.80M | -267.21% |
Net change in cash | 100.00M | 1,885.71% |
Free cash flow | 87.51M | 20.09% |
About
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,168